[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1054750A1 - Crystalline base of citalopram - Google Patents

Crystalline base of citalopram

Info

Publication number
HK1054750A1
HK1054750A1 HK03107120A HK03107120A HK1054750A1 HK 1054750 A1 HK1054750 A1 HK 1054750A1 HK 03107120 A HK03107120 A HK 03107120A HK 03107120 A HK03107120 A HK 03107120A HK 1054750 A1 HK1054750 A1 HK 1054750A1
Authority
HK
Hong Kong
Prior art keywords
citalopram
crystalline base
crystalline
base
Prior art date
Application number
HK03107120A
Other languages
English (en)
Inventor
Hans Petersen
Klaus Peter Bogeso
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1054750(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HK1054750A1 publication Critical patent/HK1054750A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Laminated Bodies (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
HK03107120A 2000-03-13 2003-10-02 Crystalline base of citalopram HK1054750A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200000402 2000-03-13
DKPCT/DK00/00183 2000-04-13
PCT/DK2001/000137 WO2001068627A1 (fr) 2000-03-13 2001-02-28 Base cristalline de citalopram

Publications (1)

Publication Number Publication Date
HK1054750A1 true HK1054750A1 (en) 2003-12-12

Family

ID=8159320

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03107120A HK1054750A1 (en) 2000-03-13 2003-10-02 Crystalline base of citalopram

Country Status (42)

Country Link
US (7) US20010031784A1 (fr)
EP (2) EP1169314B2 (fr)
JP (1) JP2003527383A (fr)
KR (1) KR20020080486A (fr)
CN (2) CN1258530C (fr)
AR (1) AR029811A1 (fr)
AT (3) ATE250050T1 (fr)
AU (2) AU746664B2 (fr)
BE (1) BE1013210A3 (fr)
BG (1) BG107065A (fr)
BR (1) BR0109373A (fr)
CA (2) CA2411732A1 (fr)
CH (2) CH691477A5 (fr)
CZ (1) CZ292077B6 (fr)
DE (7) DE20007303U1 (fr)
DK (3) DK173903B1 (fr)
EA (1) EA200200972A1 (fr)
ES (3) ES2173054T3 (fr)
FI (2) FI20010156A0 (fr)
FR (1) FR2806086B1 (fr)
GB (2) GB2357762B (fr)
GR (1) GR1003796B (fr)
HK (1) HK1054750A1 (fr)
HR (1) HRP20020756A2 (fr)
HU (3) HU0001581D0 (fr)
IE (1) IES20010109A2 (fr)
IL (2) IL158072A0 (fr)
IS (1) IS5841A (fr)
IT (2) IT1319645B1 (fr)
MX (1) MXPA02008793A (fr)
NL (2) NL1016435C1 (fr)
NO (2) NO312031B1 (fr)
PL (1) PL360158A1 (fr)
PT (2) PT1227088E (fr)
SE (2) SE517136C2 (fr)
SI (2) SI1227088T1 (fr)
SK (1) SK285528B6 (fr)
TR (1) TR200202185T2 (fr)
UA (1) UA74360C2 (fr)
WO (1) WO2001068627A1 (fr)
YU (1) YU68802A (fr)
ZA (1) ZA200207148B (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3798940B2 (ja) 1999-04-14 2006-07-19 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US7887556B2 (en) 2000-12-20 2011-02-15 Fox Hollow Technologies, Inc. Debulking catheters and methods
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
GB2376233B (en) * 2000-08-10 2003-09-10 Lundbeck & Co As H Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
JP4080874B2 (ja) 2000-12-20 2008-04-23 フォックス ハロウ テクノロジーズ,インコーポレイティド 減嵩カテーテル
KR100439329B1 (ko) * 2000-12-22 2004-07-07 하. 룬트벡 아크티에 셀스카브 순수한 시탈로프람의 제조방법
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
CN1509169A (zh) * 2001-05-01 2004-06-30 H��¡�±������޹�˾ 对映体纯艾司西酞普兰的用途
WO2003011278A1 (fr) 2001-07-31 2003-02-13 H. Lundbeck A/S Composition cristalline renfermant de l'escitalopram
WO2003057132A2 (fr) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Procede de preparation de 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurane carbonitrile
GB2387844B (en) * 2002-02-27 2005-05-11 Matrix Lab Ltd Separation of impurities from a crude mixture of citalopram
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
GB2386118A (en) * 2002-02-27 2003-09-10 Cipla Ltd Citalopram
EP1346989A1 (fr) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Procede ameliore de preparation de citalopram et de bromhydrate de citalopram
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
AU2003238676A1 (en) * 2003-04-21 2004-11-19 Podile Khadgapathi An improved process for the preparation of citalopram hydrobromide
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
GB0317475D0 (en) 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
JP4025735B2 (ja) * 2003-08-21 2007-12-26 ローム アンド ハース カンパニー 水性系を処理する方法
GB0320312D0 (en) 2003-08-29 2003-10-01 Novartis Ag Purification process
CN100569765C (zh) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
ITTO20050301A1 (it) * 2005-05-05 2006-11-06 Errekappa Euroterapici Spa Formulazioni liquide orali contenenti citalopram
EP1901714A2 (fr) * 2005-05-20 2008-03-26 Aurobindo Pharma Limited Formes posologiques pharmaceutiques d'escitalopram sous formé de granulés
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2474308A1 (fr) 2005-06-27 2012-07-11 Valeant International (Barbados) SRL Formulations pharmaceutiques contenant l'hydrobromure de bupropion
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
CA2739665C (fr) 2008-10-13 2018-01-02 Tyco Healthcare Group Lp Dispositifs et methodes de manipulation d'un axe de catheter
JP5579830B2 (ja) 2009-04-29 2014-08-27 コヴィディエン リミテッド パートナーシップ 組織を切断および研磨する方法および装置
JP5281195B2 (ja) 2009-05-14 2013-09-04 コヴィディエン リミテッド パートナーシップ 簡単に清掃され得るアテレクトミー用カテーテルおよび使用の方法
WO2011068932A1 (fr) 2009-12-02 2011-06-09 Fox Hollow Technologies, Inc. Procédés et dispositifs de coupe de tissu
EP2509519B1 (fr) 2009-12-11 2019-08-07 Covidien LP Dispositif de retrait de matériau doté d'une efficacité de capture de matériau améliorée
EP2579791B1 (fr) 2010-06-14 2014-04-23 Covidien LP Dispositif de retrait de matériau
EP2632352B1 (fr) 2010-10-28 2017-04-12 Covidien LP Dispositif d'ablation de matériau
CA2817213C (fr) 2010-11-11 2016-06-14 Covidien Lp Catheters flexibles de reduction du volume dotes de dispositifs d'imagerie et procedes d'utilisation et de fabrication de ceux-ci
JP5806407B2 (ja) 2011-09-01 2015-11-10 コヴィディエン リミテッド パートナーシップ 螺旋駆動軸を有するカテーテルおよび製造方法
US9579157B2 (en) 2012-09-13 2017-02-28 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
WO2015200702A1 (fr) 2014-06-27 2015-12-30 Covidien Lp Dispositif de nettoyage pour cathéter, et cathéter le comprenant
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2233970A (en) * 1941-03-04 Quinoline compound and process of
US2584429A (en) * 1950-12-29 1952-02-05 Rohm & Haas 1,1-diphenyl-4-tert.-amino-2-butyne-1-ols
GB1143702A (fr) * 1965-03-18
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
CA2120874E (fr) * 1994-04-08 2002-01-08 Keshava Murthy Forme de la ranitidine de forme 1
CZ291440B6 (cs) * 1997-07-08 2003-03-12 H. Lundbeck A/S Způsob výroby citalopramu
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
BR9714925A (pt) * 1997-11-11 2003-07-22 Lundbeck & Co As H Método para preparação de citalopran, composto e composição farmacêutica antidepressiva
ATE230738T1 (de) 1998-10-20 2003-01-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
JP3798940B2 (ja) 1999-04-14 2006-07-19 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
US20030078442A1 (en) 2003-04-24
DK173903B1 (da) 2002-02-11
AR029811A1 (es) 2003-07-16
EP1227088B1 (fr) 2003-09-17
NO20010619D0 (no) 2001-02-06
NL1017413C1 (nl) 2001-09-13
EP1169314A1 (fr) 2002-01-09
US20050165244A1 (en) 2005-07-28
SE526022C2 (sv) 2005-06-14
ATE223396T1 (de) 2002-09-15
IL147339A0 (en) 2002-08-14
CZ292077B6 (cs) 2003-07-16
CN1680350A (zh) 2005-10-12
NO20010619L (no) 2001-09-14
BE1013210A3 (fr) 2001-10-02
CZ2001808A3 (cs) 2002-01-16
NO312031B1 (no) 2002-03-04
HUP0100531A2 (hu) 2002-01-28
SE517136C2 (sv) 2002-04-16
ES2180471T3 (es) 2004-05-01
ES2159491B1 (es) 2002-05-01
NO315851B1 (no) 2003-11-03
WO2001068627A1 (fr) 2001-09-20
EA200200972A1 (ru) 2003-02-27
HU0100450D0 (en) 2001-04-28
PL360158A1 (en) 2004-09-06
DE10108042A1 (de) 2001-10-18
EP1227088A1 (fr) 2002-07-31
SE0200730D0 (sv) 2002-03-12
YU68802A (sh) 2005-11-28
BG107065A (bg) 2003-05-30
AT4364U1 (de) 2001-06-25
CA2360287C (fr) 2003-09-09
FI20010225A0 (fi) 2001-02-07
AU746664B2 (en) 2002-05-02
GB2357762A (en) 2001-07-04
DE60100786D1 (de) 2003-10-23
SI1169314T2 (sl) 2011-08-31
US20040167210A1 (en) 2004-08-26
FI20010156A0 (fi) 2001-01-25
SK13132002A3 (sk) 2003-01-09
IL158072A0 (en) 2004-03-28
FR2806086A1 (fr) 2001-09-14
NO20020356D0 (no) 2002-01-23
CN1258530C (zh) 2006-06-07
DK1227088T3 (da) 2003-12-22
US20060247451A1 (en) 2006-11-02
SE0103046D0 (sv) 2001-09-14
ZA200207148B (en) 2003-04-23
NL1016435C1 (nl) 2000-11-06
ATE250050T1 (de) 2003-10-15
US20040132808A1 (en) 2004-07-08
DE20121240U1 (de) 2002-07-04
CN1429220A (zh) 2003-07-09
SE0200730L (sv) 2002-08-29
SI1227088T1 (en) 2003-12-31
SE0103046L (sv) 2001-11-14
JP2003527383A (ja) 2003-09-16
EP1169314B2 (fr) 2011-06-01
DE60100022T2 (de) 2003-03-06
DE60100022D1 (de) 2002-10-10
PT1227088E (pt) 2003-12-31
ES2173054T1 (es) 2002-10-16
GR1003796B (el) 2002-02-08
IT1319645B1 (it) 2003-10-23
PT1169314E (pt) 2002-11-29
ITMI20002425A1 (it) 2002-05-09
TR200202185T2 (tr) 2002-12-23
NO20020356L (no) 2001-09-14
FI20010225A (fi) 2001-09-14
BR0109373A (pt) 2002-12-24
ES2159491A1 (es) 2001-10-01
HUP0100531A3 (en) 2004-04-28
DE60100786T2 (de) 2004-07-15
IS5841A (is) 2001-09-14
AU2001100197B4 (en) 2001-12-06
ES2173054T3 (es) 2002-12-16
KR20020080486A (ko) 2002-10-23
HU0100531D0 (en) 2001-03-28
CA2360287A1 (fr) 2001-09-20
AU3725201A (en) 2001-09-13
AU2001100197A4 (en) 2001-09-20
ES2180471T1 (es) 2003-02-16
CH691477A5 (de) 2001-07-31
US20010031784A1 (en) 2001-10-18
IES20010109A2 (en) 2002-02-20
GB0102797D0 (en) 2001-03-21
DE20007303U1 (de) 2000-07-27
HU0001581D0 (en) 2000-06-28
SK285528B6 (sk) 2007-03-01
GB2357762B (en) 2002-01-30
ITMI20010406A1 (it) 2002-08-28
DE1227088T1 (de) 2003-02-06
DK1169314T3 (da) 2002-10-14
SI1169314T1 (en) 2002-12-31
UA74360C2 (uk) 2005-12-15
US20050165092A1 (en) 2005-07-28
DE60100022T3 (de) 2011-11-17
GB0105982D0 (en) 2001-05-02
EP1169314B1 (fr) 2002-09-04
CA2411732A1 (fr) 2001-09-20
DE10164687B4 (de) 2006-04-27
MXPA02008793A (es) 2003-02-12
IL147339A (en) 2004-09-27
CH691537A5 (de) 2001-08-15
FI109022B (fi) 2002-05-15
HRP20020756A2 (en) 2004-12-31
FR2806086B1 (fr) 2003-05-09

Similar Documents

Publication Publication Date Title
GB2357762B (en) Crystalline base of citalopram
GB0007307D0 (en) Crystalline form || of cabergoline
IL152893A0 (en) Novel benzofuran derivatives
TW477164U (en) Improved structure of flowerpot
TW424905U (en) Improved structure of drum-beater
TW437338U (en) Improved adjustment structure of table
TW498715U (en) Improved structure of flowerpot
TW414059U (en) Improved structure of pot
TW466938U (en) Improved structure of pot
TW428445U (en) Positioning structure of pull-handles
TW480914U (en) Improved structure of fishpot
TW432952U (en) Improved structure of lunch-box
TW417710U (en) Modified structure of raised net-flooring
TW439422U (en) Forming structure of Juang-Yuan hat
TW461568U (en) Structure improvement of pressing-switch
TW496608U (en) Structure improvement of row-wire fixing-stage
TW441303U (en) Improved structure of cup
TW433008U (en) Improved structure of cup
TW414050U (en) Improved structure of cup
TW412996U (en) Structure of improved cup
HU0000369V0 (en) Pot for nemover of nail-polish
TW437319U (en) Improved structure of ring

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100228